Notes - Consolidated Statement Of Comprehensive Income

Kidswell Bio Corporation - Filing #7601153

Concept 2021-04-01 to
2022-03-31
2020-04-01 to
2021-03-31
Notes - Consolidated statement of comprehensive income
Notes - Consolidated single statement of comprehensive income
Research and development expenses included in general and administrative expenses and manufacturing costs for period
Research and development expenses included in general and administrative expenses and manufacturing costs for period
1,150,209,000 JPY
963,868,000 JPY
Notes regarding reclassification adjustments and tax effects relating to other comprehensive income

Talk to a Data Expert

Have a question? We'll get back to you promptly.